DOCSLIB.ORG

BDP China 2020 Update Digital.Indd

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
BDP China 2020 Update Digital.Indd 3 - 5 NOVEMBER 2020 Delivered Digitally VIEW THE AGENDA VIEW THE AGENDA VIEW THE AGENDA 30+ Interactive VIP Access NEW SPEAKERS SESSION PASS FOR IN 2020 FORMATS PHARMA Special Offer for & BIOTECH China Pharmaceutical & Knowledge Partners: Biotech Companies* Brought to you by: www.biopharmaproduction.com CHINA & GLOBAL BIOPHARMA EXPERTS NEW NEW NEW NEW Dr. Song Rulin Liu Xun Zhang Yu Executive President, China Dr. Chris Chen President, Biomedicine President and CEO, Pharmaceutical Innovation and Chief Executive Officer, Development and Business Division, Aeon Therapeutics, China Research Development Association WuXi Biologics, China Jiangsu Hengrui Medicine, China (PhIRDA), China NEW NEW NEW Dr. Orit Aharonovitz Li Jing Rong Lisa Zheng Zhang Zhe Ru Senior Vice President, Product Senior Director, Cell Line & Executive Director, Cell Line President, Head of CMC and Development and Manufacturing, Process Development, Teva Development, Transcenta, China Manufacturing, I-MAB Biopharma, CStone Pharmaceuticals, China Pharmaceuticals, Israel China NEW NEW Dr. Zhu Jianwei NEW NEW Professor and Director of MOE Lynn Yang Yin Nan Po Engineering Research Center of Cell Jerry Su Managing Director, Sequoia Capital, Director, Asia Supply Chain, Amgen, Engineering and Antibody, Shanghai Chief Executive Officer, China China Jiaotong University; CEO and Chief Zhejiang Huahai Biopharmaceuticals Scientist, Jecho Biopharmaceuticals, China NEW NEW NEW NEW John Zhang Dr. Kerstin Otte Yi Jizu Vice President, Manufacturing Professor, Institute of Applied Senior Vice President, CMC & Xi Chen Technology and Process Biotechnology, Biberach University Quality Operations, YZY Biopharma, Director, Cell Engineering, Development, BeiGene, China of Applied Sciences, Germany China Qilu Pharmaceuticals, China NEW NEW NEW NEW Ma Yuan Hui Dr. Jill Cai James Li David Shao Executive Director, Preclinical Vice President, Biologics Bioprocess Co-Founder and CEO, President, Chief Executive Officer, and Development, WuXi Biologics, JW Therapeutics, China Science, Shanghai HaiHe Yisheng Biopharma, China Pharmaceutical, China China NEW Glenn Hassan Wu You Ling Dr. Pan Zhiwei Liu Dong Lian Chief Finance Officer, Chief Business Chief Executive Officer, Senior Director, Process Vice President, Manufacturing, Officer, CANbridge Pharmaceuticals, Zhejiang Teruisi Pharmaceuticals, Development, Junshi Pharma, China TOT BIOPHARM, China China China NEW NEW Frank Ye Rani Jarkas Liang Tang Dr. Song Zhiwei Senior Vice President, Technical Chairman, Cedrus Investments, Vice President, CMC Management, Principal Scientist, Bioprocessing Operations, Transcenta, China Hong Kong WuXi Biologics, China Technology Institute, Singapore NEW NEW NEW Fu Wei Eric Chang Bao Cai Dr. Karen Liu Chief Executive Officer, CBC Group, Head, Cell Line Development, Senior Director, Manufacturing, Founding Partner, 3E Bioventures China JHL Biotech, China Bio-Thera Solutions, China Capital, China www.biopharmaproduction.com CONFERENCE AGENDA DAY 1, TUESDAY 3 NOVEMBER 2020 DAY 2, WEDNESDAY 4 NOVEMBER 2020 DAY 3, THURSDAY 5 NOVEMBER 2020 13.00 Chairperson’s Opening Remarks 16.00 Online Networking & Stretch Break 13.00 Chairperson’s Opening Remarks 15.30 CRISPR in Cell Line Development: 13.00 Chairperson’s Opening Remarks 15.50 Accelerating CLD for Commercial Success Applications of CRISPR in Rapid Development of Stable Dr. Pan Zhiwei, Senior Director, Process Development, JOINT OPENING PLENARY JOINT OPENING PLENARY 16.20 Efficient Cell Lines and Technology Applications JOINT OPENING PLENARY Transgene CHO Cell Lines Junshi Pharma, China Joint Plenary Sessions with 10th Annual Biomanufacturing and Joint Plenary Sessions with 10th Annual Biomanufacturing and Joint Plenary Sessions with 10th Annual Biomanufacturing and Lisa Zheng, Executive Director, Cell Line Development, Dr. Zhu Jianwei, Professor and Director of MOE 2nd Annual Cell & Gene Therapy Manufacturing 2nd Annual Cell & Gene Therapy Manufacturing 16.20 Online Networking & Stretch Break 2nd Annual Cell & Gene Therapy Manufacturing Transcenta, China Engineering Research Center of Cell Engineering and Antibody, Shanghai Jiaotong University; CEO and Chief 13.10 Manufacturers’ Panel: 13.10 KEYNOTE ADDRESS 13.10 KEYNOTE ADDRESS Scientist, Jecho Biopharmaceuticals, China 16.40 Using CHO to Develop Biosimilars from Non-CHO Host 16.50 Developing a New CLD Process from Ground-Up New Therapies, New Tech and New Investments China’s Biopharma Capital Markets – Future Funds and Cell Line China’s Big Leap Towards BioPharma 2030 – Innovation, • Navigating the complex landscape of strategies for • New frontiers in drug development Innovative Financing 16.00 Online Networking & Stretch Break Eric Chang, Head, Cell Line Development, JHL Biotech, Industrialization, Internationalization generating new cell lines • What is the gap in quality and investment? Fu Wei, Chief Executive Officer, CBC Group, China China Dr. Song Ru Lin, Executive President, China • Embracing new tech and start-ups to drive progress • From DNA to lead clones, what new technologies 16.20 Advances in Single-Cell Genomics and RNA Sequencing Pharmaceutical Innovation and Research Development • New therapeutics manufacturing, commercialisation 13.40 Venture Capitals Roundtable: and core instrumentation may impact future protein Tools for Effective CLD* 17.10 A Fully Integrated Platform Approach for Highly-Quality Association (PhIRDA), China and global access Show Me the Drug CLD expression and cell line development campaigns? Session Reserved for Namocell • Biomanufacturing 4.0 – Where are we at? • Investment landscape of Chinese biopharma market • Case study in Henlius’ in-house capabilities across Mark Stockdale, Amalgamator of Business and Biology, • DAL’s GAMP and licensing laws – How is it affecting • Evaluating drug pipelines and development prospects the entire biologics value chain spanning across: 13.40 KEYNOTE ADDRESS Solentim, U.K. 16.50 Next-Generation Cell Line Engineering for our business and what we can expect? • Mergers, expansion and JVs – Where do we see - High-titer cell lines; China’s Biological Facilities for the Future – WuXi’s Story Biopharmaceutical Production • The GQCE framework – quality consistency and transactions picking up? - Proprietary cell culture production; and on Technology and Innovation • Advancing microRNA to optimize and boost 17.20 High-Throughput Cloning Screening and Performance better pricing • Financing new plants, new therapeutics, product - Continuous manufacturing process for commercial Dr. Chris Chen, Chief Executive Officer, WuXi Biologics, for Next-Generation Innovative Therapeutics productivity of cell line growth launch and scaling-up operations – How do we production Panelists: China Ting Chen, Director, Alphamab Oncology, China • Use cases and applications of CRISPR/Cas9- review? Senior Representative from Shanghai Henlius Biotech, Jerry Su, Chief Executive Officer, Zhejiang Huahai mediated knockout for enhanced titre • Manufacturing 4.0 – How do VCs and banks play a China 14.10 Online Networking & Stretch Break Biopharmaceuticals, China • Identifying bottlenecks in CLD: a streamlined and part in modernising the value chain? 17.50 Expanding Beyond Traditional Monoclonal Antibodies in Glenn Hassan, Chief Finance Officer, Chief Business high-throughput approach 17.40 Panel Discussion: What’s Next in the Future of CLD&E Cell Line Development Officer, CANbridge Pharmaceuticals, China (tentatively th Dr. Kerstin Otte, Professor, Institute of Applied Panelists: • What is the next thing in medicine that we will need to 9 Annual Cell Line Development & Engineering Asia • Use case for the generation of the highest titer confirming) Biotechnology, Biberach University of Applied Sciences, Rani Jarkas, Chairman, Cedrus Investments, Hong Kong produce? Commences William Cao, Founder, Chairman & CEO, Gracell production cell lines in under 1 week Germany Judith Li, Partner, Lilly Asia Ventures, China • Biotechnologies Group, China A look ATMPs, tissue generation, stem cells, • A look at how pharma is moving cell line development Dr. Karen Liu, Founding Partner, 3E Bioventures Capital, exosomes and more 14.20 Chairperson’s Opening Remarks earlier in the therapeutic development timeline 17.20 Applications for Glycan Analysis Workflows and China 14.00 Online Networking & Stretch Break • The landscape for CRISPR: how ready or willing is the Dr. Orit Aharonovitz, Senior Director, Cell Line & Process • Delivering >99% monoclonality with every campaign Bioanalytical Proteins* Lynn Yang, Managing Director, Sequoia Capital, China industry to use CRISPR for cell line engineering? Development, Teva Pharmaceuticals, Israel Dr. John Zhu, Partner, 6 Dimensions Capital, China through optimizing your CLD workflow 9th Annual Cell Line Development & Engineering Asia Senior Representative from ProZyme • Partnerships and ventures for furthering biopharma Dr. John Proctor, Senior Vice President, Marketing, R&D capabilities and strategies Resumes 14.20 Online Networking & Stretch Break THE STATE-OF-PLAY FOR CLD Berkeley Lights, U.S. 17.50 Industry Panel: Utilising Platform Technologies for CLD 14.20 Chairperson’s Opening Remarks • Navigating the systems and various methods to Moderator: 9 th Annual Cell Line Development & Engineering Asia 14.30 OPENING KEYNOTE accomplish their goals; comparing and contrasting Dr. Song Zhiwei, Principal Scientist, Bioprocessing 18.20 End of Conference Day 1 Resumes Optimising Cell Line Development: Applications for ENGINEERING HOST CELL LINES, GENOMICS tools Technology Institute,
Load more

Recommended publications
  • ASIAN Athletics 2 0 1 7 R a N K I N G S
    ASIAN athletics 2 0 1 7 R a n k i n g s compiled by: Heinrich Hubbeling - ASIAN AA Statistician – C o n t e n t s Page 1 Table of Contents/Abbreviations for countries 2 - 3 Introduction/Details 4 - 9 Asian Continental Records 10 - 60 2017 Rankings – Men events 60 Name changes (to Women´s Rankings) 61 - 108 2017 Rankings – Women events 109 – 111 Asian athletes in 2017 World lists 112 Additions/Corrections to 2016 Rankings 113 - 114 Contacts for other publications etc. ============================================================== Abbreviations for countries (as used in this booklet) AFG - Afghanistan KGZ - Kyrghizstan PLE - Palestine BAN - Bangladesh KOR - Korea (South) PRK - D P R Korea BHU - Bhutan KSA - Saudi Arabia QAT - Qatar BRN - Bahrain KUW - Kuwait SGP - Singapore BRU - Brunei LAO - Laos SRI - Sri Lanka CAM - Cambodia LBN - Lebanon SYR - Syria CHN - China MAC - Macau THA - Thailand HKG - Hongkong MAS - Malaysia TJK - Tajikistan INA - Indonesia MDV - Maldives TKM - Turkmenistan IND - India MGL - Mongolia TLS - East Timor IRI - Iran MYA - Myanmar TPE - Chinese Taipei IRQ - Iraq NEP - Nepal UAE - United Arab E. JOR - Jordan OMA - Oman UZB - Uzbekistan JPN - Japan PAK - Pakistan VIE - Vietnam KAZ - Kazakhstan PHI - Philippines YEM - Yemen ============================================================== Cover Photo: MUTAZ ESSA BARSHIM -World Athlet of the Year 2017 -World Champion 2017 -World 2017 leader with 2.40 m (achieved twice) -undefeated during the 2017 season 1 I n t r o d u c t i o n With this booklet I present my 29th consecutive edition of Asian athletics statistics. As in the previous years I am very grateful to the ASIAN ATHLETICS ASSOCIATION and its secretary and treasurer, Mr Maurice Nicholas as well as to Mrs Regina Long; without their support I would not have been able to realise this project.
    [Show full text]
  • Top Times: China
    Top Times China All Time Olympic Events* All Ages Male & Female Time FINA Swimmer Date of Birth Age Place Meet Date Men 50 LCM Freestyle 1 21.79 883 Yu, Hexin Jan 1, 1996 24 1st CHN National Qingdao (prelims) Sep 26, 2020 2 21.91 869 Ning, Zetao Mar 6, 1993 20 1st Chinese National Games Shenyang (prelims) Sep 4, 2013 3 21.95 864 Shi, Run Jiang Jan 1, 1988 21 1st CHN Nationals Beijing Aug 29, 2009 4 22.19 836 Cai, Li Aug 14, 1987 21 1st CHN Nationals Shaoxing Apr 5, 2009 4 22.19 836 Zhao, Xianjian Oct 5, 1995 22 2nd China National Games (semis) Aug 31, 2017 4 22.19 836 Shi, Yang Jan 4, 1989 28 2nd China National Games Aug 31, 2017 7 22.28 826 Lu, Zhiwu Mar 18, 1989 20 2nd CHN Nationals Shaoxing (semis) Apr 5, 2009 8 22.29 825 You, Tianyu Jan 1, 1988 21 2nd China National Games Jinan Oct 17, 2009 9 22.31 823 Huang, Shaohua Jan 1, 1984 25 3rd China National Games Jinan Oct 17, 2009 10 22.33 821 Jiang, Chengji Jan 1, 1975 21 (T)4th 1996 Olympic Games Atlanta Jul 20, 1996 11 22.37 816 Liu, Yu Jan 1, 1982 27 4th China National Games Jinan Oct 17, 2009 11 22.37 816 He, Junyi Aug 2, 1997 23 2nd CHN Swim Series Jan 1, 2021 13 22.41 812 Zhu, Sunxiao Jan 1, 1999 20 2nd CHN Nationals Qingdao Mar 24, 2019 14 22.43 810 Wang, Changhao Jan 1, 2002 19 2nd CHN Nationals Qingdao Apr 30, 2021 15 22.46 806 Guo, Wei Aug 13, 1996 19 3rd CHN Nationals Foshan Apr 3, 2016 Men 100 LCM Freestyle 1 47.65 954 Ning, Zetao Mar 6, 1993 21 1st CHN Nationals Oct 14, 2014 2 48.10 927 He, Junyi Aug 2, 1997 21 1st CHN Nationals Qingdao Mar 24, 2019 3 48.33 L 914 Lu, Zhiwu
    [Show full text]
  • Social Enterprises from the Perspective of Political Economy: Time Attribute, Possible Path and Development Prospect
    Tenth Asia Pacific Regional Conference of the International Society for Third Sector Research (ISTR) "Global Challenges and Sustainability in the Asia Pacific: the Role of the Third Sector" Jakarta, 2-3 December 2017 at MM-CSR Trisakti University Campus, Jakarta, Indonesia Paper Proposal Submission Form Submission Deadline: 31 AUGUST 2017 Submission using this form only is considered for review. Submission is also received by email only to: [email protected] You will receive a confirmation upon receipt of your submission. Title: Social Enterprises from the Perspective of Political Economy: Time Attribute, Possible Path and Development Prospect Keywords (5 keywords maximum) Social enterprise; political economy; economic and social transformation; governance; innovation Related Conference Theme: Social Enterprise Abstract (between 500 and 800 words in length, excluding bibliography): Under the background of China's social and economic transformation, especially under the policy of structural reform, the social and economic vitality has been stimulated, and the virtuous relationship between the government and the market has been raised again. The diversification of the economic field is in full swing. As a manifestation of the diversification of modern production relations, social enterprise is a new corporate governance structure and a new production relationship. It is a new economic growth point and a reflection and practice of new development thinking. The social enterprise not only conforms to the overall law of economic operation, but also can promote the multi-level goal of economic development, and based on its own characteristics and external factors of multi-support, its regularity and purpose of the unity of the actual conditions have been basically available.
    [Show full text]
  • Dean's List Australia
    THE OHIO STATE UNIVERSITY Dean's List SPRING SEMESTER 2020 Australia Data as of June 15, 2020 Sorted by Zip Code, City and Last Name Student Name (Last, First, Middle) City State Zip Fofanah, Osman Ngunnawal 2913 Wilson, Emma Rose Jilakin 6365 THE OHIO STATE UNIVERSITY OSAS - Analysis and Reporting June 15, 2020 Page 1 of 142 THE OHIO STATE UNIVERSITY Dean's List SPRING SEMESTER 2020 Bahamas Data as of June 15, 2020 Sorted by Zip Code, City and Last Name Student Name (Last, First, Middle) City State Zip Campbell, Caronique Leandra Nassau Ferguson, Daniel Nassau SP-61 THE OHIO STATE UNIVERSITY OSAS - Analysis and Reporting June 15, 2020 Page 2 of 142 THE OHIO STATE UNIVERSITY Dean's List SPRING SEMESTER 2020 Belgium Data as of June 15, 2020 Sorted by Zip Code, City and Last Name Student Name (Last, First, Middle) City State Zip Lallemand, Martin Victor D Orp Le Grand 1350 THE OHIO STATE UNIVERSITY OSAS - Analysis and Reporting June 15, 2020 Page 3 of 142 THE OHIO STATE UNIVERSITY Dean's List SPRING SEMESTER 2020 Brazil Data as of June 15, 2020 Sorted by Zip Code, City and Last Name Student Name (Last, First, Middle) City State Zip Rodrigues Franklin, Ana Beatriz Rio De Janeiro 22241 Marotta Gudme, Erik Rio De Janeiro 22460 Paczko Bozko Cecchini, Gabriela Porto Alegre 91340 THE OHIO STATE UNIVERSITY OSAS - Analysis and Reporting June 15, 2020 Page 4 of 142 THE OHIO STATE UNIVERSITY Dean's List SPRING SEMESTER 2020 Canada Data as of June 15, 2020 Sorted by Zip Code, City and Last Name City State Zip Student Name (Last, First, Middle) Beijing
    [Show full text]
  • Notice of Filing of Application/S for Alien Employment Permit/S (Aep/S)
    PM-NCR-03.01-F.05 NOTICE OF FILING OF APPLICATION/S FOR ALIEN EMPLOYMENT PERMIT/S (AEP/S) Notice is hereby given that the following companies/Employers have filed with this Regional Office application/s for Alien Employment Permit/s: Name and Address of Company/Employ Name of Foreign Position National/Citizenship 1 24/7 BUSINESS PROCESSING INC. Huang, Yaohua Customer Service 5th - 7th Floor, 81 Newport BL, Newport City, Brgy. Representative (Chinese 183, Pasay City, Metro Manila Chinese Accounts) 2 24/7 BUSINESS PROCESSING INC. Yuan, Qiaona Customer Service 5th - 7th Floor, 81 Newport BL, Newport City, Brgy. Representative (Chinese 183, Pasay City, Metro Manila Chinese Accounts) 3 24/7 BUSINESS PROCESSING INC. Wang, Junjun Customer Service 5th - 7th Floor, 81 Newport BL, Newport City, Brgy. Representative (Chinese 183, Pasay City, Metro Manila Chinese Accounts) 4 24/7 BUSINESS PROCESSING INC. Luo, Wenli Customer Service 5th - 7th Floor, 81 Newport BL, Newport City, Brgy. Representative (Chinese 183, Pasay City , Metro Manila Chinese Accounts) 5 24/7 BUSINESS PROCESSING INC. Liu, Shiwei Customer Service 5th - 7th Floor, 81 Newport BL, Newport City, Brgy. Representative (Chinese 183, Pasay City , Metro Manila Chinese Accounts) If you have any information/objection to the above mentioned application/s, please communicate with the Regional Director thru Employment Promotion and Workers Welfare (EPWW) Division with Telephone No. 400-6011. ATTY. SARAH BUENA S. MIRASOL ATTY. SARAH BUENA S. MIRASOL REGIONAL DIRECTOR Page 1 of 223 PM-NCR-03.01-F.05 NOTICE OF FILING OF APPLICATION/S FOR ALIEN EMPLOYMENT PERMIT/S (AEP/S) Notice is hereby given that the following companies/Employers have filed with this Regional Office application/s for Alien Employment Permit/s: Name and Address of Company/Employ Name of Foreign Position National/Citizenship 6 24/7 BUSINESS PROCESSING INC.
    [Show full text]
  • Shanghai 2018
    Men's 100m Diamond Discipline 12.05.2018 Start list 100m Time: 20:53 Records Lane Athlete Nat NR PB SB 1 Isiah YOUNG USA 9.69 9.97 10.02 WR 9.58 Usain BOLT JAM Berlin 16.08.09 2 Andre DE GRASSE CAN 9.84 9.91 10.15 AR 9.91 Femi OGUNODE QAT Wuhan 04.06.15 AR 9.91 Femi OGUNODE QAT Gainesville 22.04.16 3 Justin GATLIN USA 9.69 9.74 10.05 NR 9.99 Bingtian SU CHN Eugene 30.05.15 4 Bingtian SU CHN 9.99 9.99 10.28 NR 9.99 Bingtian SU CHN Beijing 23.08.15 5 Chijindu UJAH GBR 9.87 9.96 10.08 WJR 9.97 Trayvon BROMELL USA Eugene 13.06.14 6 Ramil GULIYEV TUR 9.92 9.97 MR 9.69 Tyson GAY USA 20.09.09 7 Yoshihide KIRYU JPN 9.98 9.98 DLR 9.69 Yohan BLAKE JAM Lausanne 23.08.12 8 Zhenye XIE CHN 9.99 10.04 SB 9.97 Ronnie BAKER USA Torrance 21.04.18 9 Reece PRESCOD GBR 9.87 10.03 10.39 2018 World Outdoor list 9.97 +0.5 Ronnie BAKER USA Torrance 21.04.18 Medal Winners Shanghai previous 10.01 +0.8 Zharnel HUGHES GBR Kingston 24.02.18 10.02 +1.9 Isiah YOUNG USA Des Moines, IA 28.04.18 2017 - London IAAF World Ch. in Winners 10.03 +0.8 Akani SIMBINE RSA Gold Coast 09.04.18 Athletics 17 Bingtian SU (CHN) 10.09 10.03 +1.9 Michael RODGERS USA Des Moines, IA 28.04.18 1.
    [Show full text]
  • Inoue Yuichi（1916-1985） 1916 Born in Tokyo 1985 Died of Liver Cancer on 15 June Selected Solo Exhibitions 2016 ART BASEL 20
    Inoue Yuichi（1916-1985） 1916 Born in Tokyo 1985 Died of liver cancer on 15 June Selected Solo Exhibitions 2016 ART BASEL 2016 : Inoue Yuichi, Gallery 100, Hong Kong Inoue Yuichi, 21st Century Museum of Contemporary Art, Kanazawa, Japan 2015 So Close and Far Away, Musée Tomo, Tokyo, Japan 2014 Gutestu, Gallery 100, Taipei, Taiwan 2012 Yuichi, Japan Art, Galerie Friedrich Müller, Frankfurt, Germany Yuichi, Ningbo Museum of Art, China 2010 Yuichi, Tokushima Kenritsu Bungaku Shodokan, Japan 2008 Kanji Art of Inoue Yuichi, Shi Fang Art Museum, Zhengzhou, China 2005 Inoue Yuichi, Hangzhou International Calligraphy Art Festival, China Academy of Art, Hangzhou, China 2000 Yuichi Vivant, Chigasaki City Museum of Art, Kanagawa Yuichi Ali, d’Ac Galleria Comunale d’Arte Contemporanea di Ciampino, Italy 1999 Inoue Yuichi – Calligraphy Is for everyone, Seoul Art Center, Korea 1995 Yuichi: 1916-1985, Kunsthalle Basel, Switzerland 1989 Yuichi works 1955-85, The National Museum of Modern Art, Kyoto; Travels to Fukuoka Prefectural Museum of Art, Fukuoka; Niigata City Art Museum, Niigata; The Yamaguchi Prefectural Museum of Art, Yamaguchi; The Ehime Prefectural Museum of Art, Ehime; Koriyama City Museum of Art, Fukushima 1986 Yuichi: Zeppitsu (Yuichi, Psyché Calligraphy-Parting Thoughts), NEWZ, Tokyo; Travels to UNAC SALON, Tokyo; Nishinomiya Citizen’s Gallery, Hyogo Yuichi and Yen Chen Ch’ing, NEWZ, Tokyo 1965 Yuichi, Galerie Rudolf ZWIRNER, Cologne, Germany Selected Group Exhibitions 2015 Calligraphic Abstraction, Seattle Art Museum, Asian Art Museum,
    [Show full text]
  • Source and Profile of Paralytic Shellfish Poisoning Toxins In
    Source and profile of paralytic shellfish poisoning toxins in shellfish in Daya Bay, South China Sea Wang Zhao-Hui, Nie Xiang-Ping, Jiang Shi-Jun, Zhang Jian-Gang, Cao Yu, Zhang Yu-Juan, Wang Da-Zhi To cite this version: Wang Zhao-Hui, Nie Xiang-Ping, Jiang Shi-Jun, Zhang Jian-Gang, Cao Yu, et al.. Source and profile of paralytic shellfish poisoning toxins in shellfish in Daya Bay, South China Sea. Marine Environmental Research, Elsevier, 2011, 72 (1-2), pp.53. 10.1016/j.marenvres.2011.04.007. hal-00720180 HAL Id: hal-00720180 https://hal.archives-ouvertes.fr/hal-00720180 Submitted on 24 Jul 2012 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Accepted Manuscript Title: Source and profile of paralytic shellfish poisoning toxins in shellfish in Daya Bay, South China Sea Authors: Wang Zhao-Hui, Nie Xiang-Ping, Jiang Shi-Jun, Zhang Jian-Gang, Cao Yu, Zhang Yu-Juan, Wang Da-Zhi PII: S0141-1136(11)00050-X DOI: 10.1016/j.marenvres.2011.04.007 Reference: MERE 3523 To appear in: Marine Environmental Research Received Date: 12 July 2010 Revised Date: 18 March 2011 Accepted Date: 28 April 2011 Please cite this article as: Zhao-Hui, W., Xiang-Ping, N., Shi-Jun, J., Jian-Gang, Z., Yu, C., Yu-Juan, Z., Da-Zhi, W.
    [Show full text]
  • Starting Antihypertensive Drug Treatment with Combination Therapy
    University of Texas Rio Grande Valley ScholarWorks @ UTRGV School of Medicine Publications and Presentations School of Medicine 3-2021 Starting Antihypertensive Drug Treatment With Combination Therapy Zhen-Yu Zhang Yu-Ling Yu Kei Asayama Tine W. Hansen Gladys E. Maestre The University of Texas Rio Grande Valley, [email protected] See next page for additional authors Follow this and additional works at: https://scholarworks.utrgv.edu/som_pub Part of the Chemicals and Drugs Commons, and the Diseases Commons Recommended Citation Zhang Zhen-Yu, Yu Yu-Ling, Asayama Kei, Hansen Tine W., Maestre Gladys E., & Staessen Jan A. (2021). Starting Antihypertensive Drug Treatment With Combination Therapy. Hypertension, 77(3), 788–798. https://doi.org/10.1161/HYPERTENSIONAHA.120.12858 This Article is brought to you for free and open access by the School of Medicine at ScholarWorks @ UTRGV. It has been accepted for inclusion in School of Medicine Publications and Presentations by an authorized administrator of ScholarWorks @ UTRGV. For more information, please contact [email protected], [email protected]. Authors Zhen-Yu Zhang, Yu-Ling Yu, Kei Asayama, Tine W. Hansen, Gladys E. Maestre, and Jan A. Staessen This article is available at ScholarWorks @ UTRGV: https://scholarworks.utrgv.edu/som_pub/265 Hypertension REVIEW Starting Antihypertensive Drug Treatment With Combination Therapy Controversies in Hypertension - Con Side of the Argument Zhen-Yu Zhang , Yu-Ling Yu , Kei Asayama , Tine W. Hansen , Gladys E. Maestre , Jan A. Staessen
    [Show full text]
  • Table of Contents
    JOURNAL OF METEOROLOGLCAL RESEARCH Vol.1 1987 CONTENTS No.1 Article Warm Congratulations on Publication of Acta Meteorologica Sinica ............. Zou Jingmeng (邹竞蒙) i A Starting Point .................................................................................................. Ye Duzheng (叶笃正) ii Run AMS in English Well ......................................................................................... Tao Shiyan (陶诗言) iii The Oscillation of Certain Zonal Mean Characteristics of Motion on a Spheric Earth’s Atmosphere ......... ........................................................................................................................................ Xie Yibing 1-9 Symmetric and Asymmetric Motions in the Barotropic Filtered Model Atmosphere ................................. ..................................................................................................... Liao Dongxian, and Zou Xiaolei 10-19 The Adjustment of Wind to Ekman Flow within the Planetary Boundary Layer ......................................... ................................................................................................................ Xu Yinzi, and Wu Rongskeng 20-25 An Objective Scheme for Long-Range Forecasts ....................................................................................... ..................................................................................... Zhang Jijia,Sun Zhaobo, and Zhang Banglin 26-33 Predictability Levels of Monthly Forecast Based on Time-Averaged Ocean/Atmosphere Variables
    [Show full text]
  • 2019 Asia/Oceania Championships: Double Gold for China in Relays
    15 NOV 2019 2019 ASIA/OCEANIA CHAMPIONSHIPS: DOUBLE GOLD FOR CHINA IN RELAYS 2019 Asia/Oceania Championships: Double gold for China in relays China emerged on top in the relay events at the 2019 Asia/Oceania Championships, becoming Asian champions in both the Men’s and Mixed Relay. Korea continued their dominance from the individual finals by claiming the Women’s Relay title, but they were forced to settle for silver and bronze in the other relays as the host nation took control. There were also medals for Japan, Uzbekistan and Kyrgyzstan as the senior championships drew to a close in Wuhan (CHN), where the Laser Run and Tetrathlon (youth categories) continue until November 21. Women’s Relay Korea (Kim Sunwoo & Kim Unju) won gold by a convincing margin of 45sec from Japan (Rena Shinazu & Shino Yamanaka), with China (Zhang Xiaonan & Gu Yewen) picking up the bronze. China (Zhang/Gu) topped the standings in the Fencing Ranking Round with 29V/11D, while the fastest swimmers were the second China team (Zhang Mingyu & Wei Danni) with a time of 2:08.54. However, it was Korea (Kim/Kim) who held their nerve best in the Riding, a score of 289 enabling them to take the overall lead. They protected their lead with a Laser Run time of 12:06 and victory was never in doubt. Men’s Relay China (Zhang Linbin & Luo Shuai) won the host nation’s first gold medal of the competition as they consigned Korea (Lee Jihun & Jun Woongtae) to silver, with Kyrgyzstan (Vassilii Lukianov & Radion Khripchenko) claiming bronze.
    [Show full text]
  • Men's 100M Diamond Discipline 12.05.2018
    Men's 100m Diamond Discipline 12.05.2018 Start list 100m Time: 20:53 Records Lane Athlete Nat NR PB SB 1 Isiah YOUNG USA 9.69 9.97 10.02 WR 9.58 Usain BOLT JAM Berlin 16.08.09 2 Andre DE GRASSE CAN 9.84 9.91 10.15 AR 9.91 Femi OGUNODE QAT Wuhan 04.06.15 AR 9.91 Femi OGUNODE QAT Gainesville 22.04.16 3 Justin GATLIN USA 9.69 9.74 10.05 NR 9.99 Bingtian SU CHN Eugene 30.05.15 4 Bingtian SU CHN 9.99 9.99 10.28 NR 9.99 Bingtian SU CHN Beijing 23.08.15 5 Chijindu UJAH GBR 9.87 9.96 10.08 WJR 9.97 Trayvon BROMELL USA Eugene 13.06.14 6 Ramil GULIYEV TUR 9.92 9.97 MR 9.69 Tyson GAY USA 20.09.09 7 Yoshihide KIRYU JPN 9.98 9.98 DLR 9.69 Yohan BLAKE JAM Lausanne 23.08.12 8 Zhenye XIE CHN 9.99 10.04 SB 9.97 Ronnie BAKER USA Torrance 21.04.18 9 Reece PRESCOD GBR 9.87 10.03 10.39 2018 World Outdoor list 9.97 +0.5 Ronnie BAKER USA Torrance 21.04.18 Medal Winners Shanghai previous 10.01 +0.8 Zharnel HUGHES GBR Kingston 24.02.18 10.02 +1.9 Isiah YOUNG USA Des Moines, IA 28.04.18 2017 - London IAAF World Ch. in Winners 10.03 +0.8 Akani SIMBINE RSA Gold Coast 09.04.18 Athletics 17 Bingtian SU (CHN) 10.09 10.03 +1.9 Michael RODGERS USA Des Moines, IA 28.04.18 1.
    [Show full text]